Clinical Trials Directory

Trials / Unknown

UnknownNCT02533154

Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Benzalkonium chloride (BAC) is a preservative, which is a component of more than 70% of topical ophthalmic drugs. Although BAC is a preservative with an excellent antibacterial spectrum, it has also been shown to induce toxic effects to the ocular surface. Several studies have indicated that BAC may also have altering effects on the bacterial flora of the conjunctiva. Since dry eye syndrome (DES) is a very common and multifactorial disease of the ocular surface and the tear fluid resulting in tear film instability, inflammation of the ocular surface, symptoms of discomfort and visual impairment, there are many different preserved as well as preservative-free ophthalmic preparations of ocular lubricants for the treatment of DES. Unpublished data from our department shows differences between artificial tears for the treatment of DES with and without BAC in bacterial culture. Therefore, the aim of this study is to investigate the effect of artificial tear eyedrops with and without BAC on the conjunctival bacterial flora. For this 40 patients with mild or moderate dry eye syndrome with no use of artificial tears in the 4 weeks preceding the study will be recruited and treated either with the preservative-free "Prosicca sine" eyedrops or the BAC containing "Prosicca" eyedrops for one month. Conjunctival samples will be collected of one eye of each patient before and after the 1-month treatment period to compare the conjunctival bacterial flora of the two treatment groups.

Conditions

Interventions

TypeNameDescription
DRUGProsiccaProsicca eyedrops Dosage: on demand Route of administration: topical
DRUGProsicca sineProsicca sine eyedrops Dosage: on demand Route of administration: topical
OTHERBacterial culturebacterial cultures obtained with conjunctival swabs

Timeline

Start date
2015-07-27
Primary completion
2023-09-01
Completion
2023-10-01
First posted
2015-08-26
Last updated
2022-04-07

Locations

2 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT02533154. Inclusion in this directory is not an endorsement.